Wound healing and anti-inflammatory effects of recombinant human angiogenin

New effective wound healing agents are a priority for modern clinical pharmacology. A promising approach would be to develop medicinal products that promote angiogenesis, which is a critical step in wound healing. The aim of the study was to evaluate the wound healing effect of a medicinal product based on recombinant human angiogenin in gel form in various experimental models. Materials and methods: white outbred male rats were used as experimental ani mals. The study compared healing effects of a regenerating product containing recombinant human angiogenin (0.0025%) in gel form and a reference product in full-thickness excision, incision, and burn wound models. The healing effect of the test product in treating chronic wounds was assessed in a model of alloxan-induced diabetes mellitus. The anti-inflammatory effect of the test product containing recombinant human angiogenin was compared with that of another reference product in a model of adjuvant-induced arthritis. Results: according to the study, the test product based on recombinant human angiogenin exerts higher wound healing effect in treating excision, incision, and burn wounds than the reference product (Solcoseryl gel). Being applied, the test product intensifies tissue repair in chronic wounds in the model of alloxan-induced diabetes. The dissociation of necrotic tissues and the progression towards epithelialisation at wound edges are more rapid. The anti-inflammatory effect of the test product based on recombinant human angiogenin is comparable with that of the reference product (Diclofenac gel). Conclusions: the test product based on recombinant human angiogenin in gel form was found to have pronounced wound healing and anti-inflammatory effects comparable with those of reference products.

1. Gulyayev AY, Lokhvitski SV, Tusupkhanov BA. Wound healing effects of man’s recombined angiogenin. Medicina i èkologiâ = Medicine and Ecology. 2010;3:9– 12 (In Russ.)

2. Komolova GS, Ionova II. Biological functions and therapeutic properties of angiogenins. Eksperimentalnaya i klinicheskaya farmakologiya = Experimental and Clinical Pharmacology. 2010;73:40– 4 (In Russ.)

3. Koutroubakis IE, Xidakis C, Karmiris K, Sfiridaki A, Kandidaki E, Kouroumalis EA. Serum angiogenin in inflammatory bowel disease. Dig Dis Sci. 2004;49:1758–62. https://doi.org/10.1007/s10620004-9565-4

4. King TV, Vallee BL. Neovascularisation of the meniscus with angiogenin. An experimental study in rabbits. J Bone Joint Surg Br. 1991;73(4):587–90. https://doi.org/10.1302/0301-620x.73b4.1712788

5. Goncalves KA, Silberstein L, Li S, Severe N, Hu MG, Yang H, et al. Angiogenin promotes hematopoietic regeneration by dichotomously regulating quiescence of stem and progenitor cells. Cell. 2016;166(4):894– 906. https://doi.org/10.1016/j.cell.2016.06.042

6. Yu D, Cai Y, Zhou W, Sheng J, Xu Z. The potential of angiogenin as a serum biomarker for diseases: systematic review and meta-analysis. Dis Markers. 2018:1984718. https://doi.org/10.1155/2018/1984718

7. Sheng J, Xu Z. Three decades of research on angiogenin: a review and perspective. Acta Biochim Biophys Sin (Shanghai). 2016;48(5):399–410. https://doi.org/10.1093/abbs/gmv131

8. Newman AC, Nakatsu MN, Chou W, Gershon PD, Hughes CCW. The requirement for fibroblasts in angiogenesis: fibroblast-derived matrix proteins are essential for endothelial cell lumen formation. Mol Biol Cell. 2011;22(20):3791–800. https://doi.org/10.1091/mbc.E11-05-0393

9. Etoh T, Shibuta K, Barnard GF, Kitano S, Mori M. Angiogenin expression in human colorectal cancer: the role of focal macrophage infiltration. Clin Cancer Res. 2000;6(9):3545–51.

10. Hartmann A, Kunz M, Köstlin S, Gillitzer R, Toksoy A, Bröcker EB, Klein CE. Hypoxia-induced up-regulation of angiogenin in human malignant melanoma. Cancer Res. 1999;59(7):1578–83.

11. Lee SH, Kim KW, Joo K, Kim JC. Angiogenin ameliorates corneal opacity and neovascularization via regulating immune response in corneal fibroblasts. BMC Ophthalmol. 2016;16:57. https://doi.org/10.1186/s12886-016-0235-z

12. Matousek J, Soucek J, Riha J, Zankel TR, Benner SA. Immunosuppressive activity of angiogenin in comparison with bovine seminal ribonuclease and pancreatic ribonuclease. Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology. 1995;112(2):235–41. https://doi.org/10.1016/03050491(95)00075-5

13. Oikonomou KA, Kapsoritakis AN, Kapsoritaki AI, Manolakis AC, Tiaka EK, Tsiopoulos FD, et al. Angiogenin, angiopoietin-1, angiopoietin-2, and endostatin serum levels in inflammatory bowel disease. Inflamm Bowel Dis. 2011;17(4):963–70. https://doi.org/10.1002/ibd.21410

14. Moreau C, Devos D, Gosset P, Brunaud-Danel V, Tonnel A-B, Lassalle P, et al. Mécanismes de dérégulation de la réponse à l’hypoxie dans la sclérose latérale amyotrophique [Mechanisms of deregulated response to hypoxia in sporadic amyotrophic lateral sclerosis: a clinical study]. Rev Neurol (Paris). 2010;166(3):279–83. https://doi.org/10.1016/j.neurol.2009.05.018

15. Liu XH, Bai CG, Xu ZY, Huang SD, Yuan Y, Gong DJ, Zhang JR. Therapeutic potential of angiogenin modified mesenchymal stem cells: angiogenin improves mesenchymal stem cells survival under hypoxia and enhances vasculogenesis in myocardial infarction. Microvasc Res. 2008;76(1):23–30. https://doi.org/10.1016/j.mvr.2008.02.005

16. Weiss S, Zimmermann G, Pufe T, Varoga D, Henle P. The systemic angiogenic response during bone healing. Arch Orthop Trauma Surg. 2009;129(7):989–97. https://doi.org/10.1007/s00402-008-0777-5

17. Ibraimov AC, Beisembaev AA, Davydov VT, Omurbekov TO. The effect of angiogenin on reparative processes in an experimental aseptic wound of the liver. In: Morphology and Surgery: Collection of scientific works of NSMA. Novosibirsk; 2002. P. 61–2 (In Russ.)

18. Kulbachaev BC, Ibraimov AC. Regenerative processes in an experimental liver wound with intraoperative use of recombinant human angiogenin gel. Khirurgiya, morfologiya, limfologiya = Surgery, Morphology, Lymphology. 2003;1:37–41 (In Russ.)

19. White R, McIntosh C. A review of the literature on topical therapies for diabetic foot ulcers. Part 2: advanced treatments. J Wound Care. 2009;18(8):335–41. https://doi.org/10.12968/jowc.2009.18.8.43633

20. Langer A, Rogowski W. Systematic review of economic evaluations of human cell-derived wound care products for the treatment of venous leg and diabetic foot ulcers. BMC Health Serv Res. 2009;9:115. https://doi.org/10.1186/1472-6963-9-115

21. Toktombaev KK, Gabitov AH. Experimental substantiation of the possibility of using angiostimulating technologies in surgery. Vestnik KRSU = Herald of KRSU. 2009;9(1):162–4 (In Russ.)

22. Gulyayev AY, Tusupkhanov BA. Stimulation of wound repair processes by angiogenin in experiment. Medicina i èkologiâ = Medicine and Ecology. 2010;3:54–56 (In Russ.)

23. Purtov AA, Mamaev AL. Recombinant plasmid for expression in Pichia pastoris yeast gene of chimeric protein of human angiogenin and strain of Pichia pastoris yeast — producer of recombinant chimeric protein of human angiogenin. Patent of the Russian Federation No. 2658758; 2018 (In Russ.)

24. Gushchin YA, Kovaleva MA. Comparative morphology of skin of human and laboratory animals. Laboratornye zhivotnye dlya nauchnych issledovanii = Laboratory Animals for Science. 2019;2 (In Russ.)] https://doi.org/10.29296/2618723X-2019-02-06

25. Lomaeva SV, Gette IF, Bulavintseva TS, Perevedentseva SE, Danilova IG. The exchange of connective tissue biopolymers in the liver of alloxan diabetic rats. Bûlleten' sibirskoj mediciny = Bulletin of Siberian Medicine. 2013;12(6):38–42 (In Russ.)

26. Trinus FP, Mokhort NA, Klebanov BM. Non-Steroidal Anti-Inflammatory Drugs. Kiev: Health; 1975 (In Russ.)

27. Ham A, Cormack D. Histology. In 5 volumes. M.: Mir; 1982 (In Russ.)

28. Kittel B, Ruehl-Fehlert C, Morawietz G, Klapwijk J, Elwell MR, Lenz B, et al. Revised guides for organ sampling and trimming in rats and mice — Part 2. a joint publication of the RITA and NACAD groups. Exp Toxicol Pathol. 2004;55(6):413–31. https://doi.org/10.1078/0940-2993-00349

29. Yarmolinskaya MI, Andreyeva NY, Abashova EI, Misharina EV. Experimental models of type 1 diabetes. Zhurnal akusherstva i zhenskikh bolezney = Journal of Obstetrics and Women’s Diseases. 2019;68(2):109–18 (In Russ.) https://doi.org/10.17816/JOWD682109-118